Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

被引:410
|
作者
Takahashi, Yoshihisa [1 ]
Soejima, Yurie [1 ]
Fukusato, Toshio [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan
关键词
Animal model; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Metabolic syndrome; Histopathology; ACTIVATED-RECEPTOR-ALPHA; CHOLINE-DEFICIENT DIET; METHIONINE ADENOSYLTRANSFERASE 1A; FRUCTOSE-ENRICHED DIETS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DB/DB MICE; HEPATIC INFLAMMATION; OXIDATIVE STRESS; NATURAL-HISTORY;
D O I
10.3748/wjg.v18.i19.2300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma. NAFLD is regarded as a hepatic manifestation of metabolic syndrome and incidence has been increasing worldwide in line with the increased prevalence of obesity, type 2 diabetes, and hyperlipemia. Animal models of NAFLD/NASH give crucial information, not only in elucidating pathogenesis of NAFLD/NASH but also in examining therapeutic effects of various agents. An ideal model of NAFLD/NASH should correctly reflect both hepatic histopathology and pathophysiology of human NAFLD/NASH. Animal models of NAFLD/NASH are divided into genetic, dietary, and combination models. In this paper, we review commonly used animal models of NAFLD/NASH referring to their advantages and disadvantages. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2300 / 2308
页数:9
相关论文
共 50 条
  • [21] Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Kage, Masayoshi
    Aishima, Shinichi
    Kusano, Hironori
    Yano, Hirohisa
    JOURNAL OF MEDICAL ULTRASONICS, 2020, 47 (04) : 549 - 554
  • [22] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
    Younossi, Zobair M.
    LIVER TRANSPLANTATION, 2018, 24 (02) : 166 - 170
  • [23] The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Kazankov, Konstantin
    Jorgensen, Simon Mark Dahl
    Thomsen, Karen Louise
    Moller, Holger Jon
    Vilstrup, Hendrik
    George, Jacob
    Schuppan, Detlef
    Gronbaek, Henning
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (03) : 145 - 159
  • [24] The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Konstantin Kazankov
    Simon Mark Dahl Jørgensen
    Karen Louise Thomsen
    Holger Jon Møller
    Hendrik Vilstrup
    Jacob George
    Detlef Schuppan
    Henning Grønbæk
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 145 - 159
  • [25] Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Esterson, Yonah B.
    Grimaldi, Gregory M.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 93 - +
  • [26] Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Golabi, Pegah
    Bush, Haley
    Younossi, Zobair M.
    CLINICS IN LIVER DISEASE, 2017, 21 (04) : 739 - 753
  • [27] Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Gawrieh, Samer
    Chalasani, Naga
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 189 - +
  • [28] Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Younossi, Zobair
    Tacke, Frank
    Arrese, Marco
    Sharma, Barjesh Chander
    Mostafa, Ibrahim
    Bugianesi, Elisabetta
    Wong, Vincent Wai-Sun
    Yilmaz, Yusuf
    George, Jacob
    Fan, Jiangao
    Vos, Miriam B.
    HEPATOLOGY, 2019, 69 (06) : 2672 - 2682
  • [29] Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Sakamoto, Michiie
    Tsujikawa, Hanako
    Effendi, Kathryn
    Ojima, Hidenori
    Harada, Kenichi
    Zen, Yoh
    Kondo, Fukuo
    Nakano, Masayuki
    Kage, Masayoshi
    Sumida, Yoshio
    Hashimoto, Etsuko
    Yamada, Gotaro
    Okanoue, Takeshi
    Koike, Kazuhiko
    PATHOLOGY INTERNATIONAL, 2017, 67 (01) : 1 - 7
  • [30] Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Kogachi, Shannon
    Noureddin, Mazen
    CLINICAL THERAPEUTICS, 2021, 43 (03) : 455 - 472